Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$99.26

-0.01 (-0.01%)

11:10
02/13/19
02/13
11:10
02/13/19
11:10

Call spreads in Procter and Gamble as shares reach new highs

Call spreads in Procter and Gamble as shares reach new highs. The stock up 8c to $99.34 and 9.7K Mar 100 - Apr 105 calls bought for 81c. The investor (probably an overwriter) bought March 100 calls, probably to close a matching position sold-to-open at 85c on 2/1 with shares $97.50. With the stock approaching the 100 strike, the calls are being rolled up five strikes and to April, which expire the same day as the company's estimated 4/18/19 earnings reporting date.

  • 18

    Feb

  • 03

    Mar

  • 06

    Mar

PG Procter & Gamble
$99.26

-0.01 (-0.01%)

01/24/19
STFL
01/24/19
NO CHANGE
Target $95
STFL
Hold
P&G report has positive read-through for Estee Lauder, says Stifel
Stifel analyst Mark Astrachan believes Procter & Gamble's (PG) better than expected Q2 sales growth and raise in full-year sales guidance suggest the 4% organic sales growth rate in the first half of the fiscal year is reasonable for the second half. He raised his price target on P&G shares to $95 from $93 but keeps a Hold rating on the stock, as he anticipates consensus EPS will remain largely unchanged. Discussing read-throughs from the consumer giant's report, Astrachan said he sees the continued strong growth for prestige beauty brand SK-II as favorable for Estee Lauder (EL) and called heightened innovation in laundry something to watch for Church & Dwight (CHD).
01/24/19
RHCO
01/24/19
NO CHANGE
Target $95
RHCO
Hold
Procter & Gamble price target raised to $95 from $85 at SunTrust
SunTrust analyst William Chappell raised his price target on Procter & Gamble to $95 after its better than expected Q2 results and a raise in its FY19 organic sales growth expectations to 2%-4% from 2%-3%. The analyst is keeping his Hold rating however, stating that while the management is seeing "positive signs out of most of its key categories, much of the outperformance is due to market share momentum". At its current valuation, Chappell believes that the good news for the company are priced in.
01/24/19
01/24/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) upgraded to Hold from Sell at Berenberg with analyst James Targett saying his analysis showed large brands trend to outperform, particularly in home care, hygiene and parts of personal care and packaged food. 2. Restaurant Brands (QSR) upgraded to Outperform from Market Perform at BMO Capital with analyst Peter Sklar citing the company's announced dividend increase, strong preliminary comparable sales for Q4, and the appointment of an industry "operator" as CEO. 3. Incyte (INCY) upgraded to Buy from Hold at Gabelli and to Outperform from Market Perform at William Blair. 4. Kimberly-Clark (KMB) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying while its initial FY19 EPS guidance of $6.50-6.70 was 2.5% below the prior consensus at the midpoint, he views it as "reasonable." 5. Southern Company (SO) upgraded to Neutral from Sell at Citi with analyst Praful Mehta saying he believes the company's Vogtle site is showing "good progress" following a visit. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
EXAN
02/11/19
UPGRADE
Target $67
EXAN
Neutral
Exane upgrades Colgate-Palmolive to Neutral, names Kimberly-Clark top pick
Exane BNP Paribas analyst Jeff Stent upgraded Colgate-Palmolive (CL) to Neutral from Underperform and raised his price target for the shares to $67 from $56. Investor interest in Colgate will continue to build with its organic sales growth trends set to improve and with a management change "seemingly close," Stent tells investors in a research note. The analyst also raised his price target for Procter & Gamble (PG) to $95 from $86 and keeps an Underperform rating on the name. The company's near-term organic growth has an "upside bias," but this is already reflect in the stock following the "recent meteoric re-rating," Stent contends. In taking his Home and Personal Care coverage to three stocks, the analyst today also initiated coverage of Kimberly-Clark (KMB) with an Outperform rating and $130 price target. Kimberly-Clark is Stent's preferred way to play the U.S. Home and Personal Care space. While the company faces structural challenges, "if ever there is a time to buy, it is now" as the input cost picture improves and industry pricing is "starting to kick in," he says.

TODAY'S FREE FLY STORIES

16:37
02/20/19
02/20
16:37
02/20/19
16:37
General news
API crude inventories for week of February 15 »

API reports that crude…

TMST

TimkenSteel

$12.34

-0.08 (-0.64%)

16:37
02/20/19
02/20
16:37
02/20/19
16:37
Hot Stocks
Breaking Hot Stocks news story on TimkenSteel »

TimkenSteel sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

KALU

Kaiser Aluminum

$109.77

2.16 (2.01%)

16:37
02/20/19
02/20
16:37
02/20/19
16:37
Earnings
Kaiser Aluminum sees FY19 low to mid-single digit percent increase in shipments »

Overall, for the full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CDE

Coeur Mining

$5.55

0.045 (0.82%)

16:36
02/20/19
02/20
16:36
02/20/19
16:36
Hot Stocks
Coeur Mining reports Q4 gold production 92.5K oz vs. 118.8K oz last year »

Reports Q4 silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

JKHY

Jack Henry

$132.86

-0.03 (-0.02%)

16:36
02/20/19
02/20
16:36
02/20/19
16:36
Initiation
Jack Henry initiated  »

Jack Henry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 12

    Mar

TMST

TimkenSteel

$12.34

-0.08 (-0.64%)

16:35
02/20/19
02/20
16:35
02/20/19
16:35
Earnings
TimkenSteel reports Q4 EPS (89c), consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

KALU

Kaiser Aluminum

$109.77

2.16 (2.01%)

16:35
02/20/19
02/20
16:35
02/20/19
16:35
Earnings
Kaiser Aluminum reports Q4 EPS $1.77, consensus $1.54 »

Reports Q4 revenue $389M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CDE

Coeur Mining

$5.55

0.045 (0.82%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Earnings
Coeur Mining reports Q4 EPS 8c, consensus (11c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

BSQR

Bsquare Corp

$2.18

(0.00%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Hot Stocks
Bsquare Corp names Ralph Derrickson as President and CEO »

Bsquare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SVM

Silvercorp Metals

$2.57

0.05 (1.98%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Hot Stocks
Silvercorp says shares 'undervalued,' commences share repurchase program »

Silvercorp Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRC

Spirit Realty

$39.34

-0.48 (-1.21%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Earnings
Spirit Realty sees FY19 AFFO $3.32-$3.38, consensus $3.39 »

Sees FY19 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

SRC

Spirit Realty

$39.34

-0.48 (-1.21%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Earnings
Spirit Realty reports Q4 AFFO $1.06, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

NDSN

Nordson

$138.81

-0.42 (-0.30%)

16:33
02/20/19
02/20
16:33
02/20/19
16:33
Hot Stocks
Nordson reports Q1 backlog $439M, up 9% from last year. »

CEO Michael Hilton said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:33
02/20/19
02/20
16:33
02/20/19
16:33
Hot Stocks
Breaking Hot Stocks news story on Synopsys »

Synopsys sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Synopsys sees FY19 adjusted EPS $4.20-$4.27, consensus $4.24 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Boston Beer sees FY19 EPS $8.00-$9.00, consensus $8.51 »

Sees FY19 national price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

SUI

Sun Communities

$114.00

-0.61 (-0.53%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Sun Communities reports Q4 FFO $1.03, consensus $1.03 »

Reports Q4 revenue $274M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TS

Tenaris

$27.38

0.48 (1.78%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Tenaris reports Q4 EPS 38c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    May

NDSN

Nordson

$138.81

-0.42 (-0.30%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Nordson reports Q1 adjusted EPS 92c, consensus $1.12 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Synopsys sees Q2 adjusted EPS $1.07-$1.12, consensus $1.05 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

OMCL

Omnicell

$84.04

1.04 (1.25%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Conference/Events
Omnicell management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Earnings
Boston Beer reports Q4 EPS $1.86, consensus $1.70 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HCSG

Healthcare Services

$39.96

-0.37 (-0.92%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Conference/Events
Healthcare Services management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Options
Preliminary option volume of 17.7M today »

Preliminary option volume…

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Synopsys reports Q1 EPS $1.08, consensus 97c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.